• Profile
Close

Evaluation of the blood pressure effects of diltiazem vs metoprolol in the acute treatment of atrial fibrillation with rapid ventricular rate

The American Journal of Emergency Medicine Oct 07, 2020

Cruz SN, DeMott JM, Peksa GD, et al. - Researchers sought to determine the blood pressure effects of diltiazem intravenous push (IVP) vs metoprolol IVP in the acute management of atrial fibrillation with rapid ventricular rate (AF with RVR). They conducted a single-center, retrospective cohort study of 160 patients who presented to the emergency department (ED) between January 2012 and September 2018 in AF with RVR. Of these patients, 80 received diltiazem and 80 metoprolol. The change in systolic blood pressure (SBP) within 1 hour of initial medication administration was assessed as the primary outcome. Repeat doses within one hour, rate control to < 110 beats per minute, and SBP < 90 mmHg or decrease by > 40% within 3 hours were assessed as the secondary outcomes. Per outcomes among included patients, the blood pressure effects of diltiazem IVP vs metoprolol IVP in the acute management of AF with RVR did not differ significantly.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay